Mr Loganathan S, AVP, Onesource Biopharma

September 18, 2026 - 15:35
 0  0
Mr Loganathan S, AVP, Onesource Biopharma


Speaker in this video:
Mr Loganathan S, AVP, Onesource Biopharma

Topic: The strategic shift: Why CDMOs are becoming central to pharma growth

Key Highlights:
[1] Drug delivery combinations are the fastest-growing CDMO segment, with US DDC sales rising 16% annually, driven mainly by GLP-1s and biologics.

[2] OneSource offers end-to-end capability, from cell line development through to drug device assembly and commercial manufacturing.

[3] OneSource combines strong technical acumen with worldwide quality and regulatory expertise across its manufacturing operations.

The post Mr Loganathan S, AVP, Onesource Biopharma appeared first on Express Pharma.

Apa Reaksi Anda?

Suka Suka 0
Kurang Suka Kurang Suka 0
Setuju Setuju 0
Tidak Setuju Tidak Setuju 0
Bagus  Bagus 0
Berguna Berguna 0
Hebat Hebat 0
Edusehat Platform Edukasi Online Untuk Komunitas Kesehatan Agar Mendapatkan Informasi Dan Pengetahuan Terbaru Tentang Kesehatan Dari Nasional Maupun Internasional. || An online education platform for the health community to obtain the latest information and knowledge about health from both national and international sources.